The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
September 7th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
AACE Introduces New Obesity Treatment Module & Toolkit
Timothy Garvey, MD, FACE, Professor at the University of Alabama at Birmingham, and Chair of the AACE Obesity Scientific Committee, provided an overview of the AACE Module and Tool Kit for Obesity Medicine at the 24th Annual Scientific & Clinical Congress in Nashville, TN.
Helicobacter Pylori and Type 2 Diabetes Mellitus: More GI Upset with Metformin
May 12th 2015China's type 2 diabetes mellitus (T2DM) epidemic continues to be a pervasive, costly health care issue, with proportions surpassed only by epidemic here in the US. The majority of T2DM treatment guidelines recommend metformin as the first-line anti-hyperglycemic agent for diabetes management due to its relative safety, tolerability, and cost-effectiveness.
Pay-for-Performance in Diabetes: Sorting the Good from the Not-so-Good
May 12th 2015As P4P strategies gain popularity, the need for accurate assessment tools becomes more and more apparent-many physicians support PCP but believe that current measures are inaccurate. A common problem is that physicians appear to be penalized if they treat the elderly or patients who have reduced access to care or drug treatment.
The End of SGR: What Took So Long?
May 8th 2015For more than a decade, it has been an annual ritual to read headlines about a crisis brewing in Congress as it struggled to avert a looming Medicare disaster stemming from the imminent pay cut to Medicare physicians mandated by the "SGR". Like a broken record each time, spurred by warnings of physician groups of the dire consequences the slash in Medicare fees would have on medical practices and Medicare patients, Congress scrambled at the 12th hour to put off the mandated cuts for another year.
Diabetes Diagnosis Opens a Window of Opportunity for Weight Loss
May 5th 2015When patients are initially diagnosed with type 2 diabetes, clinicians usually recommend several lifestyle changes, including weight loss. Few studies have looked at weight changes in patients with type 2 diabetes around initial diagnosis, although it's clear that it is more difficult for patients with diabetes to lose weight than it is for others.
Chronic Itch: Gastrointestinal Peptides as Possible Contributors
May 5th 2015Chronic itch (itch last 6 weeks or longer) is a clinical challenge, and is associated with a number of dermatologic, systemic, neuropathic, and psychogenic causes. Transmission of the itch sensation is similar to that of pain, but distinct in several ways. Scientists have found itch-specific neuronal pathways that when activated, cause considerable discomfort for patients. Current available treatments, however, are still more trial-and-error than evidence-based.
Is Hair Restoration Worth the Risk of Potential Persistent Sexual Side Effects?
May 5th 2015Hair loss, whether it's partial or complete, is troubling to many people. By age 50, 35 to 50 percent of American men have significant hair loss, and hair thinning and loss increases with age. Many people associate hair loss with premature aging, making pharmaceuticals that arrest hair loss quite popular. However, they are not without certain side effects.
Liver Meeting Draws 11,000 to Vienna
An estimated 11,000 attendees from 105 countries are converging in Vienna, Austria for the 50th International Liver Congress, hosted by the European Association for the Study of the Liver (ILC/EASL). Some 200 journalists -- including a team from MD Magazine--are on hand to report the news. Eagerly awaited trials include those of two drugs that show promise for treating a common liver disease associated with obesity, known medically as non-alcoholic steatohepatitis (NASH) and its precursor non-alcoholic fatty liver disease (NAFLD).
Diet & Diabetes Prevention: Does the Specific Diet Matter?
April 22nd 2015The American Diabetes Association recommends eating fewer calories of better quality to prevent diabetes. Researchers looked at the available evidence from studies that examined a variety of diets and found that any healthy diet reduces the risk of diabetes by about 20%.